1. Home
  2. PXED vs PCRX Comparison

PXED vs PCRX Comparison

Compare PXED & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix Education Partners Inc.

PXED

Phoenix Education Partners Inc.

HOLD

Current Price

$28.34

Market Cap

980.1M

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$0.00

Market Cap

949.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
PCRX
Founded
1976
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.1M
949.9M
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
PXED
PCRX
Price
$28.34
N/A
Analyst Decision
Buy
Analyst Count
7
Target Price
$44.29
N/A
AVG Volume (30 Days)
71.8K
N/A
Earning Date
04-07-2026
09-06-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
1.69
N/A
Revenue
N/A
N/A
Revenue This Year
$3.85
N/A
Revenue Next Year
$4.49
N/A
P/E Ratio
$17.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.52
N/A
52 Week High
$38.19
N/A

Technical Indicators

Market Signals
Indicator
PXED
PCRX
Relative Strength Index (RSI) 58.60 62.77
Support Level $29.24 $21.97
Resistance Level $31.32 $26.94
Average True Range (ATR) 0.88 0.66
MACD 0.33 0.26
Stochastic Oscillator 90.44 93.15

Price Performance

Historical Comparison
PXED
PCRX

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: